Terray Therapeutics

Join our incredible team!

Terray Therapeutics is heading to ACS Spring 2026. Our co-founder and CEO, Jacob Berlin, Ph.D., will speak at the Presidential Event on “Human, Computer and Artificial Intelligence,” where he’ll share how a chemistry-first, AI-native approach can reshape small molecule discovery. If you’ll be at ACS Spring 2026, join the session to hear what we’ve learned so far—and what’s next—for AI in drug discovery. #ACS150 #DrugDiscovery

Last week we announced a big leap forward for universal potency models with EMMI Predict: TerraBind. TerraBind delivers best-in-class potency prediction while running 26x faster and reducing inference cost by 96% relative to standard industry potency models. A key driver of this performance is our collaboration with @nvidia and the integration of the NVIDIA cuEquivariance library. By centering its computational core on triangle attention and multiplication, TerraBind's architecture is uniquely positioned to fully leverage cuEquivariance's GPU-optimized kernels, providing a 3-4x speedup compared to standard implementations. With EMMI Predict: TerraBind at the center of our Generate-Predict-Select workflow, this combination of proprietary data, purpose-built models, and NVIDIA-accelerated hardware is transforming how we discover and optimize small-molecule therapeutics. We're excited to keep pushing the boundaries of predictive chemistry with partners like NVIDIA as we work to bring better medicines to patients faster. Read our blog terraytx.com/insights/emmi-… Read our arxiv paper arxiv.org/abs/2602.07735

Today we announced EMMI Predict: TerraBind, our universal potency model that dramatically expands Terray’s ability to move molecules to the clinic faster. Far outpacing publicly available models, TerraBind is a cornerstone of Terray’s end-to-end workflow for small molecule discovery and development. Read our blog: terraytx.com/insights/emmi-…

Thanks to all the attendees and partners who came out for @TechCrunch Disrupt to check out AWS’ breakout session with founders from @BigHatBio & @Terray_Tx, and the AWS San Francisco Startup Loft afterparty. 🎉 For more on AWS Startup Loft events, visit: go.aws/3SzJx3O

Today’s the day! We hope to see you at 10 am PDT for “Tech-Driven Biology and Chemistry: Solving Science’s Hardest Problems at Scale” at #Disrupt2022. We'll be talking with @BigHatBio and @awscloud about: 🟢 Company Building 🟢 Science Fact vs Fiction 🟢 The Future of Medicine

We are pleased to announce a new collaboration with @Terray_Tx focused on the discovery and development of novel small molecule therapeutics for diseases of #aging, including #cancer. To learn more: bit.ly/3VnQvLM

Terray is proud to announce a multi-target collaboration with @calico. The Terray and Calico teams will work together to discover and develop small molecule therapeutics for diseases of aging, including cancer. Read more here: prnewswire.com/news-releases/…

You won’t want to miss this – mark your calendars for Terray’s panel at @TechCrunch’s #Disrupt2022! We’re beyond excited to talk about solving science's hardest problems at scale with our friends at BigHat Biosciences!

We are thrilled to announce the appointment of Fiona Black, PhD, to our Scientific Advisory Board. Read more about Fiona and how she will support Terray’s mission to advance drug discovery: terraytx.com

Our CEO @JacobBerlinPhD will be presenting at @MorganStanley's Putting the Tech in Biotech conference tomorrow to discuss how Terray is meeting the challenge of #DrugDevelopment with the chemistry engine and #AI to propel drug discovery into the information age. #biotech

Tonight’s the night! We hope to see you on Clubhouse at 6 PM EDT for “Using chemistry data & AI to speed drug discovery”, the last of @Amazon Web Service’s Startup Innovation series! bit.ly/AWSTerray #biotech #startup #chemistry #AI #DrugDiscovery

Have you marked your calendar for June 2nd? We’ll be chatting with @marksbirch and Chris Cheng for the AWS Startup Innovation Series, and you won’t want to miss it. Save the date: bit.ly/AWSTerray #biotech #startup #AI #DrugDiscovery

We're beyond excited to be a part of the @AWSstartups Startup Innovation Series - come join @JacobBerlinPhD, @EliBerlin3, and @nm_dft as they talk about building a #biotech company and how we're using #AI in #DrugDiscovery. bit.ly/AWSTerray

Our executive team of pioneers and long-time leaders in #AI, medicinal #chemistry, #biology, #automation, and #nanotechnology have a vision to create a world where transformative therapeutics are at our fingertips. Ready to join #TeamTerray? We are #nowhiring! #biotechjobs

Did you miss @JacobBerlinPhD and @EliBerlin3 on @MadronaVentures’s podcast Founded and Funded? Don’t miss their conversation about lessons learned and the future of #AI in biotechnology: madrona.com/founded-and-fu…

Congratulations to @SabahOney and everyone on Team Timmerman on completion of their @climbtofight expedition! We’re honored to have supported @fredhutch and to contribute to funding research to end cancer. 📸: @ldtimmerman

We're honored to support an extraordinary cause!

We’re proud to support Terray investor and friend Sabah Öney (@sabahoney) and the entire expedition team led by Luke Timmerman (@ldtimmerman) as they climb to Mt. Everest Base Camp to support the @fredhutch Climb to Fight Cancer. @climbtofight

Terray is thrilled to welcome @fezterraytx as Head of Business and Adam D. Hughes as Head of Chemistry. Read more about how Fez and Adam will bolster Terray's world-class management team: terraytx.com